Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/11/2023 | -5.52% | JP Morgan | $90 → $81 | Maintains | Underweight |
10/03/2023 | -18.35% | Susquehanna | $77 → $70 | Maintains | Negative |
09/19/2023 | 6.15% | Stifel | → $91 | Reiterates | Hold → Hold |
09/13/2023 | 16.65% | Benchmark | $108 → $100 | Maintains | Buy |
08/31/2023 | -10.18% | Susquehanna | $88 → $77 | Downgrades | Neutral → Negative |
08/18/2023 | 18.98% | Loop Capital | $105 → $102 | Maintains | Buy |
08/16/2023 | 7.31% | Credit Suisse | $93 → $92 | Maintains | Underperform |
08/03/2023 | 4.98% | BMO Capital | $85 → $90 | Maintains | Market Perform |
08/03/2023 | 14.31% | Citigroup | $94 → $98 | Maintains | Neutral |
07/19/2023 | 4.98% | Stifel | $97 → $90 | Maintains | Hold |
07/06/2023 | -27.68% | Morgan Stanley | $62 → $62 | Reiterates | Underweight → Underweight |
06/30/2023 | 9.65% | Citigroup | → $94 | Reiterates | Neutral → Neutral |
06/09/2023 | 8.48% | Susquehanna | $89 → $93 | Maintains | Neutral |
06/06/2023 | 25.98% | Benchmark | → $108 | Reiterates | Buy → Buy |
06/05/2023 | -0.85% | B of A Securities | → $85 | Reiterates | Underperform → Underperform |
04/28/2023 | 13.15% | Stifel | $92 → $97 | Maintains | Hold |
04/28/2023 | 8.48% | Credit Suisse | $91 → $93 | Maintains | Underperform |
04/27/2023 | 10.81% | Stephens & Co. | → $95 | Reiterates | → Equal-Weight |
04/27/2023 | -27.68% | Morgan Stanley | $64 → $62 | Maintains | Underweight |
04/12/2023 | 4.98% | Wells Fargo | $95 → $90 | Maintains | Underweight |
04/10/2023 | -6.68% | Susquehanna | $86 → $80 | Maintains | Neutral |
02/17/2023 | 1.48% | JP Morgan | → $87 | Downgrades | Neutral → Underweight |
02/03/2023 | 15.48% | Stifel | $107 → $99 | Downgrades | Buy → Hold |
02/02/2023 | 0.31% | Susquehanna | $83 → $86 | Maintains | Neutral |
02/02/2023 | 1.48% | JP Morgan | $90 → $87 | Maintains | Neutral |
02/02/2023 | -0.85% | BMO Capital | $90 → $85 | Maintains | Market Perform |
02/02/2023 | -25.35% | Morgan Stanley | $67 → $64 | Maintains | Underweight |
02/02/2023 | 10.81% | Wells Fargo | $86 → $95 | Maintains | Underweight |
02/02/2023 | 7.31% | Bernstein | $110 → $92 | Maintains | Market Perform |
01/17/2023 | 2.65% | B of A Securities | $95 → $88 | Downgrades | Neutral → Underperform |
01/11/2023 | -21.85% | Morgan Stanley | $66 → $67 | Maintains | Underweight |
01/11/2023 | 4.98% | JP Morgan | $103 → $90 | Downgrades | Overweight → Neutral |
01/11/2023 | 28.31% | Keybanc | $120 → $110 | Maintains | Overweight |
01/10/2023 | 8.48% | Goldman Sachs | $102 → $93 | Downgrades | Buy → Neutral |
01/09/2023 | 4.98% | BMO Capital | $95 → $90 | Maintains | Market Perform |
01/05/2023 | 6.15% | Cowen & Co. | → $91 | Downgrades | Outperform → Market Perform |
01/04/2023 | 8.48% | Credit Suisse | $97 → $93 | Maintains | Underperform |
01/04/2023 | 10.81% | B of A Securities | $104 → $95 | Downgrades | Buy → Neutral |
01/04/2023 | -5.52% | UBS | $90 → $81 | Downgrades | Neutral → Sell |
11/15/2022 | — | Raymond James | Downgrades | Market Perform → Underperform | |
11/04/2022 | -23.01% | Morgan Stanley | $67 → $66 | Maintains | Underweight |
11/03/2022 | 18.98% | Goldman Sachs | $114 → $102 | Maintains | Buy |
11/03/2022 | 16.65% | BMO Capital | $110 → $100 | Maintains | Market Perform |
11/03/2022 | 4.98% | Credit Suisse | $98 → $90 | Maintains | Underperform |
11/03/2022 | 4.98% | UBS | $97 → $90 | Maintains | Neutral |
11/03/2022 | 9.65% | Citigroup | $107 → $94 | Maintains | Neutral |
11/03/2022 | 39.97% | Keybanc | $135 → $120 | Maintains | Overweight |
10/25/2022 | 16.65% | Jefferies | → $100 | Initiates Coverage On | → Hold |
10/13/2022 | 11.98% | Barclays | $100 → $96 | Maintains | Equal-Weight |
10/12/2022 | 4.98% | Wells Fargo | $94 → $90 | Maintains | Underweight |
10/07/2022 | 24.81% | Citigroup | $123 → $107 | Downgrades | Buy → Neutral |
10/03/2022 | -21.85% | Morgan Stanley | $66 → $67 | Maintains | Underweight |
08/17/2022 | — | Vertical Research | Downgrades | Hold → Sell | |
07/28/2022 | -23.01% | Morgan Stanley | $63 → $66 | Maintains | Underweight |
07/28/2022 | 9.65% | Wells Fargo | $93 → $94 | Maintains | Underweight |
07/15/2022 | 8.48% | Wells Fargo | $88 → $93 | Maintains | Underweight |
07/12/2022 | 30.64% | Evercore ISI Group | $115 → $112 | Maintains | In-Line |
07/12/2022 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
06/28/2022 | 18.98% | Credit Suisse | → $102 | Initiates Coverage On | → Underperform |
04/28/2022 | 39.97% | JP Morgan | $117 → $120 | Maintains | Overweight |
04/28/2022 | 39.97% | Citigroup | $108 → $120 | Maintains | Buy |
04/28/2022 | 24.81% | Susquehanna | $95 → $107 | Maintains | Neutral |
04/28/2022 | 34.14% | Baird | $105 → $115 | Maintains | Neutral |
04/28/2022 | 28.31% | BMO Capital | $105 → $110 | Maintains | Market Perform |
04/28/2022 | 57.47% | Keybanc | $125 → $135 | Maintains | Overweight |
04/08/2022 | 36.47% | JP Morgan | $91 → $117 | Upgrades | Neutral → Overweight |
04/05/2022 | 34.14% | Wolfe Research | $109 → $115 | Maintains | Outperform |
03/02/2022 | 28.31% | Vertical Research | → $110 | Downgrades | Buy → Hold |
02/18/2022 | 6.15% | JP Morgan | $99 → $91 | Maintains | Neutral |
02/03/2022 | -27.68% | Morgan Stanley | $65 → $62 | Maintains | Underweight |
02/03/2022 | 23.64% | Stifel | $102 → $106 | Upgrades | Hold → Buy |
02/03/2022 | 45.81% | Keybanc | $135 → $125 | Maintains | Overweight |
01/28/2022 | 45.81% | Benchmark | → $125 | Initiates Coverage On | → Buy |
01/26/2022 | 25.98% | Barclays | → $108 | Downgrades | Overweight → Equal-Weight |
01/20/2022 | — | B of A Securities | Upgrades | Neutral → Buy | |
01/06/2022 | 44.64% | Wolfe Research | → $124 | Upgrades | Peer Perform → Outperform |
01/03/2022 | 57.47% | Keybanc | → $135 | Upgrades | Sector Weight → Overweight |
10/27/2021 | 22.48% | BMO Capital | $100 → $105 | Maintains | Market Perform |
10/11/2021 | — | Vertical Research | Upgrades | Hold → Buy | |
09/13/2021 | 10.81% | Evercore ISI Group | → $95 | Initiates Coverage On | → In-Line |
07/28/2021 | 1.48% | Credit Suisse | $93 → $87 | Maintains | Underperform |
07/14/2021 | 34.14% | Citigroup | $118 → $115 | Maintains | Buy |
07/13/2021 | 4.98% | Wells Fargo | $95 → $90 | Maintains | Underweight |
07/08/2021 | -30.01% | Morgan Stanley | $58 → $60 | Maintains | Underweight |
06/07/2021 | 25.98% | Goldman Sachs | → $108 | Upgrades | Sell → Buy |
04/28/2021 | -32.35% | Morgan Stanley | $55 → $58 | Maintains | Underweight |
04/28/2021 | 8.48% | Credit Suisse | $90 → $93 | Maintains | Underperform |
04/28/2021 | 10.81% | Wells Fargo | $93 → $95 | Maintains | Underweight |
04/14/2021 | 8.48% | Wells Fargo | $81 → $93 | Maintains | Underweight |
04/12/2021 | 9.65% | Susquehanna | $92 → $94 | Maintains | Neutral |
02/01/2021 | -35.85% | Morgan Stanley | $54 → $55 | Maintains | Underweight |
01/06/2021 | -37.01% | Morgan Stanley | $53 → $54 | Maintains | Underweight |
11/09/2020 | 37.64% | Citigroup | → $118 | Upgrades | Neutral → Buy |
11/02/2020 | 1.48% | BMO Capital | $85 → $87 | Maintains | Market Perform |
10/29/2020 | -9.02% | Wells Fargo | $92 → $78 | Maintains | Underweight |
10/29/2020 | 10.81% | Stephens & Co. | $110 → $95 | Downgrades | Overweight → Equal-Weight |
09/24/2020 | 7.31% | Wells Fargo | → $92 | Initiates Coverage On | → Underweight |
08/17/2020 | 14.31% | Baird | → $98 | Downgrades | Outperform → Neutral |
08/05/2020 | 4.98% | Deutsche Bank | $82 → $90 | Maintains | Hold |
08/03/2020 | -38.18% | Morgan Stanley | $50 → $53 | Maintains | Underweight |
07/30/2020 | 9.65% | Stifel | $79 → $94 | Downgrades | Buy → Hold |
07/30/2020 | 10.81% | Citigroup | $85 → $95 | Maintains | Neutral |
07/29/2020 | 17.81% | UBS | $94 → $101 | Maintains | Buy |
07/08/2020 | -0.85% | Citigroup | $67 → $85 | Maintains | Neutral |
06/05/2020 | 9.65% | UBS | $78 → $94 | Maintains | Buy |
06/03/2020 | 0.31% | B of A Securities | $67 → $86 | Upgrades | Underperform → Neutral |
05/04/2020 | -41.68% | Morgan Stanley | $51 → $50 | Maintains | Underweight |
04/30/2020 | -11.35% | Susquehanna | $77 → $76 | Maintains | Neutral |
04/30/2020 | -9.02% | UBS | $75 → $78 | Maintains | Buy |
04/30/2020 | -0.85% | Baird | $80 → $85 | Upgrades | Neutral → Outperform |
04/29/2020 | -21.85% | B of A Securities | $61 → $67 | Maintains | Underperform |
04/17/2020 | -0.85% | Barclays | $95 → $85 | Maintains | Overweight |
04/08/2020 | -40.51% | Morgan Stanley | $52 → $51 | Maintains | Underweight |
04/06/2020 | -12.52% | Stephens & Co. | $74 → $75 | Upgrades | Equal-Weight → Overweight |
04/01/2020 | -12.52% | UBS | $64 → $75 | Upgrades | Neutral → Buy |
03/16/2020 | -25.35% | UBS | $79 → $64 | Maintains | Neutral |
01/30/2020 | -13.68% | Stephens & Co. | $77 → $74 | Maintains | Equal-Weight |
01/30/2020 | — | Susquehanna | Downgrades | Positive → Neutral | |
01/29/2020 | -9.02% | Citigroup | $85 → $78 | Maintains | Neutral |
01/15/2020 | — | Susquehanna | Upgrades | Neutral → Positive | |
01/15/2020 | 16.65% | Barclays | → $100 | Upgrades | Equal-Weight → Overweight |
01/07/2020 | — | Wolfe Research | Upgrades | Peer Perform → Outperform | |
01/06/2020 | -33.51% | Morgan Stanley | $59 → $57 | Maintains | Underweight |
11/04/2019 | -31.18% | Morgan Stanley | $64 → $59 | Maintains | Underweight |
11/01/2019 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
10/31/2019 | -0.85% | Baird | $90 → $85 | Maintains | Neutral |
10/30/2019 | -6.68% | B of A Securities | $89 → $80 | Downgrades | Neutral → Underperform |
07/26/2019 | 2.65% | Citigroup | → $88 | Downgrades | Buy → Neutral |
05/02/2019 | 0.31% | Stephens & Co. | $93 → $86 | Maintains | Equal-Weight |
05/02/2019 | 2.65% | Citigroup | $102 → $88 | Maintains | Buy |
05/01/2019 | — | UBS | Downgrades | Buy → Neutral | |
04/04/2019 | 16.65% | Barclays | $95 → $100 | Maintains | Equal-Weight |
02/27/2019 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
10/31/2018 | 18.98% | Citigroup | $111 → $102 | Maintains | Buy |
10/18/2018 | 24.81% | Loop Capital | → $107 | Initiates Coverage On | → Buy |
What is the target price for C.H. Robinson Worldwide (CHRW)?
The latest price target for C.H. Robinson Worldwide (NASDAQ: CHRW) was reported by JP Morgan on October 11, 2023. The analyst firm set a price target for $81.00 expecting CHRW to fall to within 12 months (a possible -5.52% downside). 50 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for C.H. Robinson Worldwide (CHRW)?
The latest analyst rating for C.H. Robinson Worldwide (NASDAQ: CHRW) was provided by JP Morgan, and C.H. Robinson Worldwide maintained their underweight rating.
When is the next analyst rating going to be posted or updated for C.H. Robinson Worldwide (CHRW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of C.H. Robinson Worldwide, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for C.H. Robinson Worldwide was filed on October 11, 2023 so you should expect the next rating to be made available sometime around October 11, 2024.
Is the Analyst Rating C.H. Robinson Worldwide (CHRW) correct?
While ratings are subjective and will change, the latest C.H. Robinson Worldwide (CHRW) rating was a maintained with a price target of $90.00 to $81.00. The current price C.H. Robinson Worldwide (CHRW) is trading at is $85.73, which is out of the analyst's predicted range.